🔗 Share this article

Texas Attorney General Ken Paxton is suing the manufacturers of acetaminophen, asserting the firms concealed potential risks that the drug created to children's cognitive development.

The lawsuit comes thirty days after President Donald Trump publicized an unproven link between taking acetaminophen - also known as paracetamol - during pregnancy and autism in offspring.

The attorney general is filing suit against the pharmaceutical giant, which once produced the medication, the sole analgesic recommended for women during pregnancy, and Kenvue, which now manufacturers it.

In a official comment, he said they "misled consumers by gaining financially from suffering and marketing drugs without regard for the potential hazards."

The company states there is insufficient reliable data tying Tylenol to autism.

"These corporations misled for generations, deliberately risking numerous people to line their pockets," the attorney general, from the Republican party, declared.

Kenvue commented that it was "seriously troubled by the spread of false claims on the reliability of paracetamol and the potential impact that could have on the health of US mothers and children."

On its online platform, the company also said it had "regularly reviewed the relevant science and there is no credible data that shows a verified association between taking acetaminophen and autism."

Groups acting on behalf of doctors and medical practitioners share this view.

The American College of Obstetricians and Gynecologists has said paracetamol - the main ingredient in Tylenol - is one of the few options for women during pregnancy to address pain and fever, which can create significant medical dangers if left untreated.

"In more than two decades of studies on the utilization of paracetamol in pregnancy, no reliable research has conclusively proven that the usage of acetaminophen in any trimester of pregnancy causes neurological conditions in offspring," the group commented.

This legal action mentions latest statements from the former administration in asserting the medication is potentially dangerous.

Last month, the former president generated worry from medical authorities when he instructed pregnant women to "struggle intensely" not to take Tylenol when sick.

Federal regulators then issued a notice that doctors should contemplate reducing the consumption of acetaminophen, while also mentioning that "a causal relationship" between the drug and autism spectrum disorder in young ones has not been proven.

Health Secretary Kennedy, who supervises the Food and Drug Administration, had vowed in spring to conduct "extensive scientific investigation" that would determine the cause of autism spectrum disorder in a limited time.

But authorities warned that identifying a unique factor of autism - thought by researchers to be the result of a complex mix of genetic and external influences - would prove challenging.

Autism is a category of enduring cognitive variation and disability that influences how people encounter and interact with the surroundings, and is diagnosed using medical professional evaluations.

In his court filing, the attorney general - a Trump ally who is seeking the Senate - alleges the manufacturer and J&J "deliberately disregarded and tried to quiet the evidence" around paracetamol and autism.

This legal action seeks to make the firms "eliminate any promotional materials" that states acetaminophen is reliable for women during pregnancy.

This legal action mirrors the complaints of a collection of guardians of minors with autism and attention deficit hyperactivity disorder who took legal action against the producers of Tylenol in 2022.

Judicial authorities rejected the legal action, declaring studies from the plaintiffs' authorities was inconclusive.